Company Search:
Advanced Search
Sponsored Links
Tissue Regenix Group PLC Company Snapshot
Tissue Regenix Group PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tissue Regenix Group PLC with three other companies in this sector in the United Kingdom: Vernalis Plc (2018 sales of £11.48 million [US$15.01 million] of which 76% was Research and development), Shield Therapeutics PLC (£11.88 million [US$15.53 million] of which 100% was Feraccru), and MaxCyte Inc (£12.53 million [US$16.38 million] of which 100% was Medical Service).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tissue Regenix Group PLC
  Stock Performance Chart for Tissue Regenix Group PLC
  Stock Data: Recent Stock Performance:
  Current Price (1/24/2020): 1.28p
(Figures in Pounds Sterling)
1 Week -17.7%   13 Weeks 27.5%  
4 Weeks -51.9%   52 Weeks -77.8%  
Tissue Regenix Group PLC Key Data:
  Ticker: TRX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 11,619,000
(Year Ending Jan 2019).
Employees: 86
  Currency: Pounds Sterling Market Cap: 14,942,634
  Fiscal Yr Ends: December Shares Outstanding: 1,171,971,322
  Share Type: Ordinary Closely Held Shares: 360,100,390
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.